MedTrace Logo

International Rare And Severe Psoriasis Expert Network

NCT04359394 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2024-05-09

No results posted yet for this study

Summary

This registry is a prospective observational study in order to describe primarily the natural course of PP subtypes and to gain detailed information about their phenotype.

Conditions

  • Pustular Psoriasis (PP)

Interventions

OTHER

biological sampling

In order to investigate the level of molecular pathophysiology, blood and punch biopsies will be collected of each patient. In up to two relatives per patient, 30mL blood will be collected only once.

OTHER

Phenotypic description

Phenotypic characterization of the patient's clinical features

OTHER

Photography

All affected areas will be photographed at each visit with 2-dimensional standardized photography

Sponsors & Collaborators

Principal Investigators

  • Alexander Navarini, Prof. Dr. med. Dr. sc. nat. · Dermatologie, Universitätsspital Basel

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-22
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Germany
  • Italy
  • Portugal
  • Singapore
  • Switzerland
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04359394 on ClinicalTrials.gov